Americans spend an estimated $60 billion a year on biologically derived medications, or biologics, to treat diseases like cancer and rheumatoid arthritis. California is home to a lot of the firms that make them and a lot of the people who use them, and the state's congressional delegation is influencing how they'll be treated in health care legislation.
Sponsored